what types of cryptocurrency are there- Top People also ask

Gold prices rose three times in a row, and brands such as Chow Tai Fook and Lao Fengxiang broke through 810 yuan. After a short-term shock, the gold trend became stronger. On December 11th, spot gold hit $2,700 per ounce, hitting a two-week high and rising for three consecutive days. As of press time, COMEX Gold reported $2,737.5 per ounce, up 0.7% in the day. In the domestic gold consumption market, the gold prices of gold brands such as Chow Tai Fook, Lao Fengxiang and Luk Fook Jewelry reached 812 yuan/gram, while the gold prices in Zhou Shengsheng reached 814 yuan/gram. (Dahe Finance Cube)The CSI A500ETF paid dividends for the first time. On December 11th, ICBC Credit Suisse announced the dividend, becoming the first CSI A500ETF product to announce the dividend. The dividend plan is to allocate 0.066 yuan for every 10 fund shares, the base date of income distribution is November 29, and the net value of fund shares on the base date is 1.0078 yuan. In addition, ICBC Credit Suisse CSI A500ETF's dividend registration date is December 13th, and the cash dividend payment date is December 18th.Qinghai Eco-environmental Industry Company was established with a registered capital of 200 million yuan. According to the enterprise search APP, recently, Qinghai Eco-environmental Industry Co., Ltd. was established with Wang Gencun as its legal representative and a registered capital of 200 million yuan. Its business scope includes: management services for ecological protection areas; Ecological resources monitoring; Environmental emergency management services; Carbon emission reduction, carbon transformation, carbon capture, carbon sequestration technology research and development, etc.

Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.Dong Xingliang, former director of the Drilling and Completion Office of CNOOC, was investigated. The website of the State Commission for Discipline Inspection of the Central Commission for Discipline Inspection reported on December 11 that according to the news of the Discipline Inspection and Supervision Team of China Offshore Oil Group Co., Ltd. and the Supervision Committee of Jiangsu Provincial Commission for Discipline Inspection, Dong Xingliang, former director of the Drilling and Completion Office of CNOOC, was suspected of serious violation of discipline and law, and is currently under the discipline inspection and supervision of the Discipline Inspection and Supervision Team of China Offshore Oil Group Co., Ltd. and the Supervision Committee of Xuzhou City, Jiangsu Province.Market news: Japan is considering levying a 4% corporate tax surcharge for national defense expenditure.

On the 11th, the director of the Crime Investigation Department of Senior Public Officials in South Korea said that if the situation is urgent, he would try to arrest the president urgently.Zhewen Internet: Zhejiang Internet (600986) announced on the evening of December 11th that the company intends to authorize the management of the company to make an independent decision to dispose of the stock of Doushen Education Technology (Beijing) Co., Ltd. (hereinafter referred to as "Doushen Education") held by the company through centralized bidding or block trading. The authorization period is within 36 months from the date of deliberation and approval by the shareholders' meeting. As of the date of announcement, the company holds 61.06 million shares of Doushen Education, accounting for 2.95% of the total share capital of Doushen Education, and will lift the restriction on sales on December 29, 2024.Jinling Pharmaceutical Co., Ltd.: Magnesium sulfate injection has obtained the drug registration certificate. Jinling Pharmaceutical Co., Ltd. announced that Nanjing Jinling Pharmaceutical Factory, a subsidiary of the company, recently received the "Drug Registration Certificate" for magnesium sulfate injection issued by National Medical Products Administration. Magnesium sulfate injection can be used for the treatment of pregnancy-induced hypertension, eclampsia and preeclampsia, and plays an important role in the prevention and treatment of many diseases. The drug has been recommended by related guides in China, the United States and Canada. This drug registration is conducive to the company's future market expansion and sales, but the production and sales of drugs may be affected by changes in policies and market environment, which is uncertain.